BioLineRx to Report First Quarter 2023 Results on May 24, 2023

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a pre-commercial-stage biopharmaceutical company focused on oncology, announced today that it…

PTC Therapeutics Announces APHENITY Trial Achieved Primary Endpoint with Sepiapterin in PKU Patients

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the primary endpoint was achieved in the APHENITY, Phase…

EXACT SCIENCES AWARDS GRANTS TO 18 ORGANIZATIONS FOCUSED ON INCREASING COLORECTAL CANCER SCREENINGS

Exact Sciences, a leading provider of cancer screening and diagnostic tests, announced today that it awarded $1.1…

The Top Channels for Influencer Marketing in 2023 [New Data]

Finding the right influencer for a brand campaign can feel like dating. You want someone who…

How Marketing Leaders are Navigating Recession [New Data]

In the last six months, economic trend surveys we’ve conducted revealed that 37% of marketers are…

15 AI SEO Tools and How to Use AI in 2023 [New Data]

Optimizing your content to rank high in search engines can be tedious, especially when there are…

MemorialCare Saddleback Medical Center Awarded ‘A’ Hospital Safety Grade from The Leapfrog Group for Sixth Consecutive Time

 MemorialCare Saddleback Medical Center received an “A” Hospital Safety Grade for Spring 2023 from The Leapfrog Group, a national…

Europe Ultrasound Device Market 2023: Increased Awareness of Early Disease Diagnosis and Technological Advancements in Ultrasound Imaging Drive Growth

The “Europe Ultrasound Device Market, Size, Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis” report…

Global In-vitro Fertilization Microscopes Market Anticipated to Garner $250.4 Million, Growing at a 9.4% CAGR in the 2022-2031 Timeframe | Defined by Research Dive

Global In-vitro Fertilization Microscopes Market Forecast Analysis: As per the report published by Research Dive, the global in-vitro…

MedAlliance Enrolls First US Patient into its Third FDA IDE Study: SFA SELUTION4SFA 

The first US patient has been enrolled in the SELUTION4SFA Sirolimus DEB study by Dr. Arthur Lee at…